N-(2-Chloro-4-pyrimidinyl)-2,3-dimethyl-2H-indazol-6-amine

Its main role is to help identify, quantify, and control potential impurities during Pazopanib’s manufacturing process, ensuring the drug’s safety and efficacy, rather than being a therapeutic agent itself. N-(2-Chloro-4-pyrimidinyl)-2,3-dimethyl-2H-indazol-6-amine is used mainly as a pharmaceutical impurity, intermediate, and reference standard in the development and quality control of the anti-cancer drug Pazopanib, a tyrosine kinase inhibitor (TKI) for treating renal cell carcinoma and soft tissue sarcoma.